Vectibix for the Treatment of Anal Cancer

NCT01285778 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Anal Squamous Cell Carcinoma

Interventions

DRUG: panitumumab, mytomicin C, 5-FU, radiation

Sponsor

Grupo Espanol Multidisciplinario del Cancer Digestivo

Collaborators

[object Object]
[object Object]